Bidde Pharmaceutical: Net profit of 152 million yuan in 2025, up 29.22% year-on-year

Bid Medical announces that in 2025, operating revenue will be 1.32B yuan, a year-on-year increase of 20.13%.
Net profit will be 152 million yuan, a year-on-year increase of 29.22%.
The company plans to distribute a cash dividend of 11.6 yuan (including tax) for every 10 shares based on a total share capital of 90.8829 million shares,
with a total planned cash dividend distribution of 99.9372 million yuan (including tax),
and the cash dividend payout ratio accounting for 65.86% of the net profit attributable to the company’s shareholders for the year.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin